Skip to content
Veroscience
  • News
  • Contact Us
  • Linkedin
  • Home
  • About Us
    • Executive Team
  • Cycloset
    • Mechanism of Action
    • Pre-Clinical Studies
    • Clinical Studies
    • U.S. Cycloset Patents
  • Pipeline
    • Cycloset for Pediatric T2DM Patients
    • VS41157 for Pancreatic Cancer
  • Technologies
    • Circadian Neuroendocrine Resetting Therapy (CNRT)
    • CNRT Overview Video References
    • Photo Immuno-Resetting Therapy for the Treatment of Cancer
  • Therapeutic Areas
    • Metabolic Diseases
    • Immunological Disorders
  • Partners & Collaborators
  • Publications
*Cycloset®

Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info

Veroscience > News
  • Share
      
  • Print

News

American Diabetes Association Abstracts 2020

  • Abstract 1
  • Abstract 2
  • Abstract 3

ADA: New Drug Cycloset Improves Glucose Control and Reduces CVD Risk

News
www.diabetesincontrol.com/ada-new-drug-cycloset-improves-glucose-control-and-reduces-cvd-risk/
Read More

VeroScience – Resetting Biological Clock Systems

News
www.youtube.com/watch?reload=9&v=rPRgMwY5rM8
Read More
« Previous 1 2
  • News
  • Archives
  • About Us
  • Executive Team
  • Cycloset
  • Mechanism of Action
  • Pre-Clinical Studies
  • Clinical Studies
  • U.S. Cycloset Patents
  • Pipeline
  • Cycloset for Pediatric T2DM Patients
  • VS41157 for Pancreatic Cancer
  • Technologies
  • Circadian Neuroendocrine Resetting Therapy (CNRT)
  • CNRT Overview Video References
  • Photo Immuno-Resetting Therapy for the Treatment of Cancer
  • Therapeutic Areas
  • Metabolic Diseases
  • Immunological Disorders
close ×
  • Partners & Collaborators
  • News
  • Publications
  • Contact Us
  • Site Map
  • Terms of Use
Website by Axxiem
© Copyright . All Right Reserved
By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). These include pieces of text that are stored on your computer or device. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT